MLchartDataset catalogue

SU5416

Term · Oncology and biomedicine · MLC-T-ONC-008354

A substance that has been studied in the treatment of cancer. It belongs to the families of drugs called angiogenesis inhibitors and tyrosine kinase inhibitors. Also called semaxanib.

Table 1. Record
IdentifierMLC-T-ONC-008354
FieldOncology and biomedicine
Expansionssemaxanib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-008354",
  "term": "SU5416",
  "field": "Oncology and biomedicine",
  "definition": "A substance that has been studied in the treatment of cancer. It belongs to the families of drugs called angiogenesis inhibitors and tyrosine kinase inhibitors. Also called semaxanib.",
  "expansions": [
    "semaxanib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/su5416/"
}

Record 15,739 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.